Assessment of Resmetirom Efficacy (80 mg vs. 100 mg) Stratified by Baseline Body Mass Index and Weight in Patients From the MAESTRO-NASH Trial
Gastroenterol Hepatol (N Y)
.
2024 Dec;20(12 Suppl 11):12-13.
PMID:
39896966
PMCID:
PMC11784561
No abstract available